Status:
COMPLETED
Increasing HPV Vaccination in Community-Based Pediatric Practices
Lead Sponsor:
Pamela Hull
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
HPV Vaccines
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolesce...
Detailed Description
Background: The human papillomavirus (HPV) vaccine offers the unprecedented opportunity to prevent nearly all cervical and anal cancers and a high proportion of vaginal, oropharyngeal, vulvar and pen...
Eligibility Criteria
Inclusion
- All providers and staff at each practice
Exclusion
- None
Key Trial Info
Start Date :
February 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT03399396
Start Date
February 21 2018
End Date
February 28 2021
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37203